Intrathecal injection of LXA4 and 17(R)-RvD1 decrease carrageenan-induced TNF levels in the CSF. by Sally Abdelmoaty (462658)

Lytic reactivation stimuli decrease Oct-2 expression. by Amanda R. Robinson (184305)

NR4A1 expression does not decrease after inhibition of p38, JNK and Src pathways. by Glenda Eger (636934)

Decrease in vRNA in brain during antiretroviral therapy. by Sonny R. Elizaldi (9684796)

IL-18 decreases TEER in Caco2 monolayers. by Ossama Allam (5043434)

“…<p>The TEER was measured during 24 hours after addition of 10 ng/ml of IL-18, 10 ng/ml IL-1β or 100 ng/ml Tat to the cell monolayers. …”

TQ decreases CXCR4 expression on MM cells and CXCL12-induced CXCR4/CD45 association. by Gamal Badr (113166)

Resveratrol decreases the mitochondrial membrane potential (ΔΨm) and induces cytochrome <i>c</i> release from mitochondria. by José Díaz-Chávez (5648905)

LPLI decreases the transcription activity of NFκB. by Jyun-Yi Wu (103136)

MPI knockdown decreases migration of human glioblastoma cells. by Aurélie Cazet (644004)

IFNAR1 is decreased on CD103⁺ DCs in the PPs of mice following treatment with La-IFN-β. by Adelle P. McFarland (229619)

TNFα decreased Best-3 expression in endothelium. by Wei Song (30780)

“…(<b>C, D</b>) HUVECs were stimulated with TNFα (10 ng/ml) for different times as indicated. Quantitative PCR (C) and western blot (D) results show a time-dependent decrease of Best-3 expression. …”

FHL2 silencing decreases osteosarcoma cell growth. by Julia Brun (286504)

NDRG2 is decreased during LX-2 activation. by Jiandong Yang (196004)

NS4B decreases TRIF protein level. by Yisha Liang (5244368)

Prostate cancer incidentally discovered at the time of radical cystoprostatectomy does not decrease overall survival: Results from a large Chinese medical center by Shiying Tang (5137418)

Decreased survival of HL60 cells after fractionated irradiation. by Annette Geltmeier (779536)

The blood plasma, kidney, and brain concentration levels (ng/ml) of GSK360A presented for 5 and 24 hours after GSK360A (30 mg/kg) was administered orally by gavage. by Jin Zhou (90734)

Immunoblotting shows PEG-FUD significantly decreased fibronectin without degradation in ECM fractions of UUO kidneys. by Bianca R. Tomasini-Johansson (5892587)

eNOS phosphorylation increased intracellular ROS generation and decreased cell viability in BH4-depleted cells. by Hu Peng (396074)

“…HEK293 eNOS control, *, <i>p</i> < 0.01). 50ng/mL VEGF caused further decrease of cell viability in eNOS overexpressing HEK293 cells treated with 10mM DAHP (VEGF plus DAHP vs. …”

Comparison of mean differences in temperature decreases. by Hans-Jörg Gillmann (8460585)